share_log

U.K. National Institute for Health and Care Excellence Approves BeiGene's BRUKINSA As Rare Lymphoma Treatment

U.K. National Institute for Health and Care Excellence Approves BeiGene's BRUKINSA As Rare Lymphoma Treatment

英国国家健康与护理卓越研究所批准百济神州的BRUKINSA作为罕见淋巴瘤的治疗
MT Newswires ·  2022/09/20 02:14

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发